These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 9846889)
21. Novel inhibitors of advanced glycation endproducts (part II). Rahbar S; Yerneni KK; Scott S; Gonzales N; Lalezari I Mol Cell Biol Res Commun; 2000 Jun; 3(6):360-6. PubMed ID: 11032758 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934 [TBL] [Abstract][Full Text] [Related]
23. Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. Saxena P; Saxena AK; Cui XL; Obrenovich M; Gudipaty K; Monnier VM Invest Ophthalmol Vis Sci; 2000 May; 41(6):1473-81. PubMed ID: 10798665 [TBL] [Abstract][Full Text] [Related]
24. Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products. Matsui T; Joo HD; Lee JM; Ju SM; Tao WH; Higashimoto Y; Fukami K; Yamagishi S Immunol Lett; 2015 Oct; 167(2):141-6. PubMed ID: 26304702 [TBL] [Abstract][Full Text] [Related]
25. Products of advanced glycation in patients with type 2 diabetes and vascular disease. Turk Z; Sesto M; Skodlar J; Ferencak G; Pokupec R; Turk N; Stavljenić-Rukavina A Ann Clin Biochem; 2003 Sep; 40(Pt 5):552-9. PubMed ID: 14503994 [TBL] [Abstract][Full Text] [Related]
26. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. Tanikawa T; Okada Y; Tanikawa R; Tanaka Y J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577 [TBL] [Abstract][Full Text] [Related]
27. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders. Yamagishi S; Nakamura K; Matsui T; Inoue H; Takeuchi M Med Hypotheses; 2007; 69(3):666-8. PubMed ID: 17331665 [TBL] [Abstract][Full Text] [Related]
28. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy. Stitt AW; Moore JE; Sharkey JA; Murphy G; Simpson DA; Bucala R; Vlassara H; Archer DB Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2517-23. PubMed ID: 9856760 [TBL] [Abstract][Full Text] [Related]
29. Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration. Chibber R; Molinatti PA; Kohner EM Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):47-57. PubMed ID: 10099839 [TBL] [Abstract][Full Text] [Related]
31. Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults. Gugliucci A; Kotani K; Taing J; Matsuoka Y; Sano Y; Yoshimura M; Egawa K; Horikawa C; Kitagawa Y; Kiso Y; Kimura S; Sakane N Ann Nutr Metab; 2009; 54(3):197-201. PubMed ID: 19420913 [TBL] [Abstract][Full Text] [Related]
32. Immunological studies on glycated human IgG. Ahmad S; Moinuddin ; Ali A Life Sci; 2012 Jun; 90(25-26):980-7. PubMed ID: 22634323 [TBL] [Abstract][Full Text] [Related]
33. Standardizing the immunological measurement of advanced glycation endproducts using normal human serum. Mitsuhashi T; Vlassara H; Founds HW; Li YM J Immunol Methods; 1997 Aug; 207(1):79-88. PubMed ID: 9328589 [TBL] [Abstract][Full Text] [Related]
34. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Münch G; Keis R; Wessels A; Riederer P; Bahner U; Heidland A; Niwa T; Lemke HD; Schinzel R Eur J Clin Chem Clin Biochem; 1997 Sep; 35(9):669-77. PubMed ID: 9352229 [TBL] [Abstract][Full Text] [Related]
35. Recent advances in detection of AGEs: Immunochemical, bioanalytical and biochemical approaches. Ashraf JM; Ahmad S; Choi I; Ahmad N; Farhan M; Tatyana G; Shahab U IUBMB Life; 2015 Dec; 67(12):897-913. PubMed ID: 26597014 [TBL] [Abstract][Full Text] [Related]
36. Usefulness of Skin Autofluorescence as a Biomarker of Acute Oxidative Stress in Young Male Japanese Long-Distance Runners: A Cross-Sectional Study. Fujiwara R; Anzai N; Ishikawa M; Takahashi A Sports (Basel); 2022 Nov; 10(11):. PubMed ID: 36422949 [TBL] [Abstract][Full Text] [Related]
37. The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases. Steenbeke M; Speeckaert R; Desmedt S; Glorieux G; Delanghe JR; Speeckaert MM Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408796 [TBL] [Abstract][Full Text] [Related]
38. Differential Effects of Dietary Patterns on Advanced Glycation end Products: A Randomized Crossover Study. Kim Y; Keogh JB; Deo P; Clifton PM Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545555 [TBL] [Abstract][Full Text] [Related]
39. Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes. Furst JR; Bandeira LC; Fan WW; Agarwal S; Nishiyama KK; McMahon DJ; Dworakowski E; Jiang H; Silverberg SJ; Rubin MR J Clin Endocrinol Metab; 2016 Jun; 101(6):2502-10. PubMed ID: 27115060 [TBL] [Abstract][Full Text] [Related]
40. Determinants of bone strength and quality in diabetes mellitus in humans. Farr JN; Khosla S Bone; 2016 Jan; 82():28-34. PubMed ID: 26211989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]